Correlation Between Vericel Corp and Molecular Partners

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Vericel Corp and Molecular Partners at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vericel Corp and Molecular Partners into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vericel Corp Ord and Molecular Partners AG, you can compare the effects of market volatilities on Vericel Corp and Molecular Partners and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vericel Corp with a short position of Molecular Partners. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vericel Corp and Molecular Partners.

Diversification Opportunities for Vericel Corp and Molecular Partners

0.32
  Correlation Coefficient

Weak diversification

The 3 months correlation between Vericel and Molecular is 0.32. Overlapping area represents the amount of risk that can be diversified away by holding Vericel Corp Ord and Molecular Partners AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Molecular Partners and Vericel Corp is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vericel Corp Ord are associated (or correlated) with Molecular Partners. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Molecular Partners has no effect on the direction of Vericel Corp i.e., Vericel Corp and Molecular Partners go up and down completely randomly.

Pair Corralation between Vericel Corp and Molecular Partners

Given the investment horizon of 90 days Vericel Corp Ord is expected to generate 0.54 times more return on investment than Molecular Partners. However, Vericel Corp Ord is 1.84 times less risky than Molecular Partners. It trades about 0.34 of its potential returns per unit of risk. Molecular Partners AG is currently generating about -0.01 per unit of risk. If you would invest  4,554  in Vericel Corp Ord on August 31, 2024 and sell it today you would earn a total of  1,222  from holding Vericel Corp Ord or generate 26.83% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Vericel Corp Ord  vs.  Molecular Partners AG

 Performance 
       Timeline  
Vericel Corp Ord 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Vericel Corp Ord are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite quite unsteady technical and fundamental indicators, Vericel Corp disclosed solid returns over the last few months and may actually be approaching a breakup point.
Molecular Partners 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Molecular Partners AG are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of very uncertain essential indicators, Molecular Partners displayed solid returns over the last few months and may actually be approaching a breakup point.

Vericel Corp and Molecular Partners Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Vericel Corp and Molecular Partners

The main advantage of trading using opposite Vericel Corp and Molecular Partners positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vericel Corp position performs unexpectedly, Molecular Partners can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Molecular Partners will offset losses from the drop in Molecular Partners' long position.
The idea behind Vericel Corp Ord and Molecular Partners AG pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.

Other Complementary Tools

Content Syndication
Quickly integrate customizable finance content to your own investment portal
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators